Publications

Export 6784 results:
Sort by: Author [ Title  (Desc)] Type Year
A B C D E F G H I J K L M N [O] P Q R S T U V W X Y Z   [Show ALL]
V
Noorzad, R., T. A. Poor, M. Omidvar, M. A. Abdou, A. A. Soliman, E. N. Aksan, A. Ozdes, E. N. Aksan, A. Ozdes, T. Ozis, et al., "Variational iteration method for one dimensional nonlinear thermoelasticity.", Journal of Applied Sciences, vol. 8, no. 2: orgz, pp. 245–251, 2005. Abstract
n/a
Elnoury, A., O. Azmy, J. Alsharnoubi, S. Salama, A. Okasha, and W. Gouda, "Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.", BMC research notes, vol. 11, issue 1, pp. 181, 2018 Mar 15. Abstract

OBJECTIVES: Pathophysiological similarity exists between gestational diabetes mellitus (GDM) and type 2 diabetes mellitus with common genetic origin. Genetic liability for GDM in our population is still not researched. The goal was to reveal the genotypic and allele frequency differences of 2 single nucleotide polymorphisms (SNPs) namely, CDKAL1 (rs7754840) and CDKN2A/2B (rs10811661) between GDM pregnancies and normal pregnancies. We assessed them by real time polymerase chain reaction using Taqmanallelic discrimination assays. We included 47 GDM pregnant subjects and 51 normal glucose tolerance (NGT) pregnant women as controls.

RESULTS: The genotype frequencies in the GDM group and the NGT group of rs7754840-GG/GC/CC were 6.4/15.7% (3/8), 55.3/45.1% (26/23) and 38.3/39.2% (18/20) respectively. Also, those of rs10811661-CC/CT/TT were 74.5/14.9/4.3% (38/7/2) and 80.9/19.6/5.9% (38/10/3) respectively. The allele frequencies in the GDM group and the NGT group of C/G and T/C were 66/34% (62/32), 61.8/38.2% (63/39) and 11.7/88.3% (11/83), 15.7/84.3% (16/86) respectively. There were no statistical differences between the two groups in allele frequencies and genotype frequencies (all P > 0.05). Non-significant association was seen in the two SNPs of CDKAL1 and CDKN2A/B genes with GDM. Further studies are essential to validate data.

Elnoury, A., O. Azmy, J. Alsharnoubi, S. Salama, A. Okasha, and W. Gouda, "Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.", BMC research notes, vol. 11, issue 1, pp. 181, 2018 Mar 15. Abstract

OBJECTIVES: Pathophysiological similarity exists between gestational diabetes mellitus (GDM) and type 2 diabetes mellitus with common genetic origin. Genetic liability for GDM in our population is still not researched. The goal was to reveal the genotypic and allele frequency differences of 2 single nucleotide polymorphisms (SNPs) namely, CDKAL1 (rs7754840) and CDKN2A/2B (rs10811661) between GDM pregnancies and normal pregnancies. We assessed them by real time polymerase chain reaction using Taqmanallelic discrimination assays. We included 47 GDM pregnant subjects and 51 normal glucose tolerance (NGT) pregnant women as controls.

RESULTS: The genotype frequencies in the GDM group and the NGT group of rs7754840-GG/GC/CC were 6.4/15.7% (3/8), 55.3/45.1% (26/23) and 38.3/39.2% (18/20) respectively. Also, those of rs10811661-CC/CT/TT were 74.5/14.9/4.3% (38/7/2) and 80.9/19.6/5.9% (38/10/3) respectively. The allele frequencies in the GDM group and the NGT group of C/G and T/C were 66/34% (62/32), 61.8/38.2% (63/39) and 11.7/88.3% (11/83), 15.7/84.3% (16/86) respectively. There were no statistical differences between the two groups in allele frequencies and genotype frequencies (all P > 0.05). Non-significant association was seen in the two SNPs of CDKAL1 and CDKN2A/B genes with GDM. Further studies are essential to validate data.

El-Noury, A., O. Azmy, J. Alsharnoubi, S. Salama, A. Okasha, and W. Gouda, "Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.", BMC research notes, vol. 11, issue 1, pp. 181, 2018 Mar 15. Abstract

OBJECTIVES: Pathophysiological similarity exists between gestational diabetes mellitus (GDM) and type 2 diabetes mellitus with common genetic origin. Genetic liability for GDM in our population is still not researched. The goal was to reveal the genotypic and allele frequency differences of 2 single nucleotide polymorphisms (SNPs) namely, CDKAL1 (rs7754840) and CDKN2A/2B (rs10811661) between GDM pregnancies and normal pregnancies. We assessed them by real time polymerase chain reaction using Taqmanallelic discrimination assays. We included 47 GDM pregnant subjects and 51 normal glucose tolerance (NGT) pregnant women as controls.

RESULTS: The genotype frequencies in the GDM group and the NGT group of rs7754840-GG/GC/CC were 6.4/15.7% (3/8), 55.3/45.1% (26/23) and 38.3/39.2% (18/20) respectively. Also, those of rs10811661-CC/CT/TT were 74.5/14.9/4.3% (38/7/2) and 80.9/19.6/5.9% (38/10/3) respectively. The allele frequencies in the GDM group and the NGT group of C/G and T/C were 66/34% (62/32), 61.8/38.2% (63/39) and 11.7/88.3% (11/83), 15.7/84.3% (16/86) respectively. There were no statistical differences between the two groups in allele frequencies and genotype frequencies (all P > 0.05). Non-significant association was seen in the two SNPs of CDKAL1 and CDKN2A/B genes with GDM. Further studies are essential to validate data.

El-Noury, A., O. Azmy, J. Alsharnoubi, S. Salama, A. Okasha, and W. Gouda, "Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.", BMC research notes, vol. 11, issue 1, pp. 181, 2018 Mar 15. Abstract

OBJECTIVES: Pathophysiological similarity exists between gestational diabetes mellitus (GDM) and type 2 diabetes mellitus with common genetic origin. Genetic liability for GDM in our population is still not researched. The goal was to reveal the genotypic and allele frequency differences of 2 single nucleotide polymorphisms (SNPs) namely, CDKAL1 (rs7754840) and CDKN2A/2B (rs10811661) between GDM pregnancies and normal pregnancies. We assessed them by real time polymerase chain reaction using Taqmanallelic discrimination assays. We included 47 GDM pregnant subjects and 51 normal glucose tolerance (NGT) pregnant women as controls.

RESULTS: The genotype frequencies in the GDM group and the NGT group of rs7754840-GG/GC/CC were 6.4/15.7% (3/8), 55.3/45.1% (26/23) and 38.3/39.2% (18/20) respectively. Also, those of rs10811661-CC/CT/TT were 74.5/14.9/4.3% (38/7/2) and 80.9/19.6/5.9% (38/10/3) respectively. The allele frequencies in the GDM group and the NGT group of C/G and T/C were 66/34% (62/32), 61.8/38.2% (63/39) and 11.7/88.3% (11/83), 15.7/84.3% (16/86) respectively. There were no statistical differences between the two groups in allele frequencies and genotype frequencies (all P > 0.05). Non-significant association was seen in the two SNPs of CDKAL1 and CDKN2A/B genes with GDM. Further studies are essential to validate data.

Elnoury, A., O. Azmy, J. Alsharnoubi, S. Salama, A. Okasha, and W. Gouda, "Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association", BMC research notes, vol. 11, no. 1: BioMed Central, pp. 1–6, 2018. Abstract
n/a
Ola, K. A., A. Arafa, H. M.K., A. El-Sanousi, and M. A. Shalaby, "Variability of Hemagglutinin Cleavage Site (HACS) Among Avian Influenza H5N1 Egyptian Viruses", Egyptian J. Virol., vol. 8, pp. 13-29, 2011.
Sabaa, M. W., R. R. Mohamed, and E. H. Oraby, "Vanillin Schiff's Bases as organic thermal stabilizers and co-stabilizers for rigid Poly (Vinyl Chloride)", European Polymer Journal, , vol. , 45, issue 11, pp. 3072-3080, 2009.
Osman, K., Tara Rava Zolnikov, K. Badr, H. Naima, M. Hanafya, A. Elbehiryd, and A. Saad, "Vancomycin and Florfenicol Resistant Enterococcus Faecalis and Enterococcus Faecium Isolated from Human Urine in an Egyptian Urban-Rural Community", Acta Tropica, vol. 201, issue 105209, 2020.
T
Saad, A. S., O. M. A. R. WAGIH, I. N. A. S. ELSHAZLY, H. I. S. H. A. M. A. B. U. ELDAHAB, and S. Osman, THE VALUE OF USING AMANTADINE UPON IMPROVING CONSCIOUS LEVEL IN ISOLATED HEAD TRAUMA PATIENTS GUIDED BY GLASGOW COMA SCALE AND BISPECTRAL INDEX, , Cairo, Cairo , 2018.
V
Elaziz, M. M. A., A. A. Fahmy, D. Hisham, and others, "The value of urine neutrophil gelatinase-associated lipocalin in the prediction of septic acute kidney injury, dialysis need, and mortality in a cohort of Eegyptian sepsis patients", Kasr Al Ainy Medical Journal, vol. 23, no. 2: Medknow Publications, pp. 80, 2017. Abstract
n/a
Omar, D. R. A. T., D. A. H. Mohamed, D. K. A. E. L. Malek, and D. M. mohamed Eid, value of third trimester cervical length assessment in predicting preterm hamorrhage in cases of placenta previa, , Egypt, Cairo university, 2014.
Nassar, Y., K. Omar, A. Battah, and A. Mwafi, "Value of the preoperative Model for End-stage Liver Disease score in predicting postoperative outcome in living donor liver transplantation recipients", Critical Care, vol. 17, issue (Suppl 2), pp. P405, 2013.
Kotb, M. H., W. Omar, T. El-Maghraby, M. El-Bedwihy, M. El-Tawdy, H. Mustafa, and A. Al-Nahhas, "The value of simultaneous co-registration of 99mTc- MDP and 131Iodine in metastatic differentiated thyroid carcinoma.", Nuclear medicine review. Central & Eastern Europe, vol. 10, issue 2, pp. 98-105, 2007. Abstract

BACKGROUND: The lack of anatomical details in standard (131)Iodine whole body scanning ((131)I WBS) interferes with the proper localization of metastatic differentiated thyroid carcinoma (DTC) lesions. In addition, nearby or overlapping variable physiological distribution of (131)I may affect the specificity of (131)I uptake, giving indeterminate results. The aim of this study was to demonstrate the clinical usefulness of simultaneous co-registration of (99m)Tc MDP bone scanning as an anatomical landmark with (131)I scanning in the evaluation of metastatic DTC.

MATERIAL AND METHODS: Twenty-five patients (16 females and 9 males, mean age +/- SD = 52 +/- 13 years) with metastatic DTC (17 papillary, 8 follicular), were included. Whole body scanning using a 256 x 1024 matrix and an 8 cm/min scan rate were obtained 48 hours after oral administration of 185-370 MBq 131I and 2 hours after IV administration of 185-370 MBq (99m)Tc MDP using a dual head gamma camera equipped with high energy parallel hole collimators. Occasionally, additional simultaneous co-registration of localised detailed images was also performed using a 256 x 256 matrix size. The two planar images were fused with optional fusion of SPECT images. The data from standard (131)I scanning and fused (131)I/ (99m)Tc-MDP scanning were separately assessed by two nuclear medicine physicians. Fusion images were considered to improve image interpretation in comparison with standard (131)I scanning when they provided better localization of lesions.

RESULTS: All lesions in the present study were validated by radiological images and clinical follow up for at least 12 months. Forty-eight metastatic lesions were confirmed as follows: 2 in the skull, 10 in the neck, 20 in the thorax, 12 in the pelvic-abdominal region and 4 in the extremities. Standard (131)I WBS showed 54 extra-thyroidal foci with 8 false positive lesions of which 2 were located in the scalp and 6 in the pelvic-abdominal region extra-skeleton (i.e. sensitivity 100%, specificity 86%). Out of the 48 validated lesions, 16 were indeterminately localized: 10 in the thorax (3 mediastinal nodal lesions, 5 vertebral lesions and 2 ribs) and 6 in the pelvic-abdominal region (2 upper sacral, 2 sacroiliac region and 2 ischial bone). Fusion images confirmed the precise localization of the pathological uptake in the validated 48 lesions (sensitivity 100%, specificity 100%). There were 2 (4%) indeterminate lesions in fused planar imaging that were clearly localized via fused SPECT images.

CONCLUSIONS: Fusion images using simultaneous co-registration of (131)I and (99m)Tc MDP scanning is a simple and feasible technique that improves the anatomically limited interpretation of scintigraphy using (131)I alone in patients with metastatic differentiated thyroid carcinoma. The diagnostic advantage of this technique seems to be more apparent in the thoracic and pelvic- abdominal regions in contrast to the neck and extremities.

Maged, A. M., A. El-Mazny, N. Kamal, S. I. Mahmoud, M. Fouad, N. El‑Nassery, amal Kotb, W. S. Ragab, A. I. Ogila, A. A. Metwally, et al., "The value of platelet‑rich plasma in women with previous implantation failure: a systematic review and meta‑analysis", Journal of Assisted Reproduction and Genetics, 2023.
Shabana, M. I., M. S. E. - M. Dabbous, and A. Osman, "The Value of Multifrequency Tympanometry in the Diagnosis of Menière’s Disease.", Med J. Cairo Univ., vol. 75, no. 3, Suppl: Cairo University, pp. 77–86, 2007. Abstract
n/a
Sheble, N., G. Hamdy, M. A. Obada, G. Y. Abouria, F. Khalaf, and E. A. Khattab, "The Value of Measurement of Circulating Tumour Cells in Hepatocellular Carcinoma", Life Science Journal, vol. 10, issue 4, pp. 1-11, 2013. ctc_2013.pdf
Wahed, N. A., G. Omar, and H. Omar, "Value of image analysis in the follow up and assessment of bone defects repair as compared to digital radiography.", Egyptian Dental Journal, vol. 53, pp. 2849- 2856, 2007.
Soheir, Z., A. Maha, H. Olfat, E. R. Maysa, S. Motaz, H. Sherin, E. K. Nabil, and S. Rabab, "Value of hepatocyte paraffin 1 antigen (Hep Par 1) and vascular endothelial growth factor (VEGF) in predicting early HCC and differentiating some metastatic hepatic lesions in patients with chronic liver disease", VIRCHOWS ARCHIV, vol. 451, no. 2: SPRINGER 233 SPRING STREET, NEW YORK, NY 10013 USA, pp. 376–377, 2007. Abstract
n/a
Soheir, Z., A. Maha, H. Olfat, E. R. Maysa, S. Motaz, H. Sherin, E. K. Nabil, and S. Rabab, "Value of hepatocyte paraffin 1 antigen (Hep Par 1) and vascular endothelial growth factor (VEGF) in predicting early HCC and differentiating some metastatic hepatic lesions in patients with chronic liver disease", VIRCHOWS ARCHIV, vol. 451, no. 2: SPRINGER 233 SPRING STREET, NEW YORK, NY 10013 USA, pp. 376–377, 2007. Abstract
n/a
Tourism